Article Information
PMID
Published By
Print ISSN
0250-7005
Online ISSN
1791-7530
History
- Received November 3, 2003
- Revision received January 20, 2003
- Accepted April 1, 2004
- Published online May 1, 2004.
Copyright & Usage
Copyright© 2004 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
Author Information
- KAZUHIRO YOSHIDA1,
- NAOKI HIRABAYASHI2,
- WATARU TAKIYAMA2,
- MOTOKI NINOMIYA3,
- NORIHISA TAKAKURA3,
- JYUNNICHI SAKAMOTO4,
- MASAHIKO NISHIYAMA5 and
- TETSUYA TOGE1
- 1Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Graduate School of Medical Science, Hiroshima University
- 2Department of Surgery, Hiroshima City Asia Hospital
- 3Department of Surgery, Hiroshima City Hospital
- 4Department of Epidemiological and Clinical Research Information Management, Kyoto University, Graduate School of Medicine, Faculty of Medicine, Japan
- 5Department of Translational Cancer Research, Research Institute for Radiation Biology and Medicine, Graduate School of Medical Science, Hiroshima University
- Correspondence to: Kazuhiro Yoshida, Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8553, Japan. Tel: +81-82-257-5866, Fax: +81-82-256-7109, e-mail: kyoshida{at}hiroshima-u.ac.jp
Statistics from Altmetric.com
Cited By...
In this issue
Jump to section
Related Articles
Cited By...
- Docetaxel, Nedaplatin, and S-1 (DGS) Chemotherapy for Advanced Esophageal Carcinoma: A Phase I Dose-escalation Study
- Feasibility Study of S-1 and Intraperitoneal Docetaxel Combination Chemotherapy for Gastric Cancer with Peritoneal Dissemination
- Docetaxel and S-1 as a First-line Treatment in Patients with Advanced or Recurrent Gastric Cancer